{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:01:53Z","timestamp":1790146913087,"version":"4.0.1"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective de-implementation approaches to reduce low-value or harmful care are limited. Prolonged antimicrobial use after skin closure is ineffective and increases harm but is nonetheless common following cardiovascular implantable electronic device (CIED) procedures. The aim of this quasi-experimental Implementation\/Effectiveness study was to use an implementation\/de-implementation (I\/D) bundle of strategies to promote de-implementation of guideline-discordant prolonged antimicrobial use and improve outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Hybrid III Implementation\/Effectiveness study grounded in learning\/unlearning theory and guided by the integrated-Promoting Action on Research Implementation in Health Services (i-PARIHS) framework with a non-randomized parallel group trial design (3 intervention and 8 control sites) over a 12-month period with an additional 12-months of follow up to assess sustainment. The I\/D bundle included: blended facilitation, local champions, provider education, and access to locally-customized audit-feedback data about facility-level guideline compliance with benchmarking, CIED infections, and antimicrobial harms (acute kidney injury, allergic events,\n                      <jats:italic>Clostridiodes difficile<\/jats:italic>\n                      infections). Implementation outcomes were assessed quantitatively using a difference-in-differences model and qualitatively; clinical outcomes were assessed quantitatively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      2,293 CIED procedures were performed at the 3 intervention sites and 5,273 at the 8 matched control sites. Following I\/D bundle intervention, rates of guideline non-compliance fell in the intervention sites but not the controls (OR, 0.16, 95% CI, 0.12\u20130.21). There was no change in CIED infections following the intervention (OR, 0.96, 95% CI, 0.48\u20131.93,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.91) and a trend toward a reduction in composite antimicrobial harms (OR\u202f=\u202f0.59; 95% CI: 0.34, 1.02,\n                      <jats:italic>p<\/jats:italic>\n                      -value\u202f=\u202f0.059). Improvements were sustained during the 12-month period after active implementation and associated with a decrease in composite harm (aOR\u202f=\u202f0.57; 95% CI: 0.34\u20130.91,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.02). Strategies identified as effective for promoting de-implementation included education, locally-customized dashboard audit-feedback data with benchmarking to high-performing sites and feedback about both harm and benefit, blended facilitation, and provider\u2019s readiness to change. Review and updating of hospital factors that promote sustainment of ineffective care, such as automated order sets, were also important. Practices learned and introduced from other practice settings were important barriers to change.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The I\/D bundle that included audit-feedback about patient-level harms of guideline discordant care was an effective strategy for reducing low-value care and improving quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:uri>ClinicalTrials.Gov<\/jats:uri>\n                      : NCT05020418.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1893058","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:20:35Z","timestamp":1790144435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Balanced informational feedback as part of an implementation\/deimplementation bundle to support deimplementation efforts in antimicrobial stewardship: results from a mixed methods, hybrid type III implementation\/effectiveness trial"],"prefix":"10.3389","volume":"14","author":[{"given":"Westyn","family":"Branch-Elliman","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, VA Greater Los Angeles Healthcare System","place":["Los Angeles, CA, United States"]},{"name":"Center for the Study of Healthcare Innovation, Implementation, and Policy (CSHIIP), Greater Los Angeles VA Medical Center","place":["Los Angeles, CA, United States"]},{"name":"Department of Medicine, UCLA David Geffen School of Medicine","place":["Los Angeles, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena H.","family":"Shin","sequence":"additional","affiliation":[{"name":"Center for Health Optimization and Implementation Research (CHOIR), VA Boston Healthcare System","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Golenbock","sequence":"additional","affiliation":[{"name":"Center for Health Optimization and Implementation Research (CHOIR), VA Boston Healthcare System","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca P.","family":"Lamkin","sequence":"additional","affiliation":[{"name":"Center for Health Optimization and Implementation Research (CHOIR), VA Boston Healthcare System","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipandita","family":"Basnet","sequence":"additional","affiliation":[{"name":"Center for Health Optimization and Implementation Research (CHOIR), VA Boston Healthcare System","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Strymish","sequence":"additional","affiliation":[{"name":"Section of Infectious Disease, VA Boston Healthcare System","place":["Boston, MA, United States"]},{"name":"Department of Medicine, Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Drekonja","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Minneapolis VA Healthcare System","place":["Minnesota, MN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rodriguez-Barradas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Michael E. DeBakey VA Medical Center","place":["Houston, TX, United States"]},{"name":"Department of Medicine, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Michael E. DeBakey VA Medical Center","place":["Houston, TX, United States"]},{"name":"Department of Medicine, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Colborn","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine","place":["Aurora, CO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin L.","family":"Schweizer","sequence":"additional","affiliation":[{"name":"Department of Medicine, William S. Middleton VA Hospital","place":["Madison, WI, United States"]},{"name":"Department of Medicine, University of Wisconsin-Madison","place":["Madison, WI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Rani","family":"Elwy","sequence":"additional","affiliation":[{"name":"Center for Health Optimization and Implementation Research (CHOIR), Bedford VA Medical Center","place":["Bedford, MA, United States"]},{"name":"Department of Psychiatry, Brown University School of Medicine","place":["Providence, RI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary J.","family":"Mull","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, VA Greater Los Angeles Healthcare System","place":["Los Angeles, CA, United States"]},{"name":"Department of Surgery, Boston University Chobanian & Avedisian School of Medicine","place":["Boston, MA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11606-007-0392-0","article-title":"Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis","volume":"23","author":"Zhan","year":"2008","journal-title":"J Gen Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail","year":"2011","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/pace.12518","article-title":"Increased long-term mortality in patients with cardiovascular implantable electronic device infections","volume":"38","author":"Rizwan Sohail","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/heartjnl-2014-306873","article-title":"Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection","volume":"101","author":"Harrison","year":"2015","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/jac\/dku383","article-title":"Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint working party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British cardiovascular society (BCS), British heart valve society (BHVS) and British Society for Echocardiography (BSE)","volume":"70","author":"Sandoe","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1540-8159.2012.03506.x","article-title":"Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery","volume":"35","author":"Darouiche","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"70","author":"Bratzler","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1001\/jamasurg.2017.0904","article-title":"Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017","volume":"152","author":"Berrios-Torres","year":"2017","journal-title":"JAMA Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1017\/ice.2023.67","article-title":"Strategies to prevent surgical site infections in acute-care hospitals: 2022 update","volume":"44","author":"Calderwood","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref10","author":"Asundi","year":"2018"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jamasurg.2019.0569","article-title":"Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events","volume":"154","author":"Branch-Elliman","year":"2019","journal-title":"JAMA Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1017\/ice.2018.170","article-title":"Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program","volume":"39","author":"Asundi","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref13","volume-title":"Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement? ID Week 2015","author":"Branch-Elliman","year":"2015"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ajic.2019.10.020","article-title":"Factors influencing uptake of evidence-based antimicrobial prophylaxis guidelines for electrophysiology procedures","volume":"48","author":"Branch-Elliman","year":"2020","journal-title":"Am J Infect Control"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13012-019-0960-9","article-title":"Unpacking the complexities of de-implementing inappropriate health interventions","volume":"15","author":"Norton","year":"2020","journal-title":"Implement Sci"},{"key":"ref16","first-page":"1","article-title":"The life cycle of infection prevention and antimicrobial stewardship projects and interventions: the dynamic interplay of implementation and de-implementation science (part I of II)","author":"Branch-Elliman","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1017\/ice.2025.75","article-title":"The life cycle of infection prevention and antimicrobial stewardship projects and interventions: the dynamic interplay of implementation and de-implementation science (Part I of II)","volume":"46","author":"Branch-Elliman","year":"2025","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref18","volume-title":"Viewing De-Implementation as a Feature of a Learning Health Care System","author":"Helfrich","year":"2020"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/jep.12855","article-title":"How the dual process model of human cognition can inform efforts to de-implement ineffective and harmful clinical practices: a preliminary model of unlearning and substitution","volume":"24","author":"Helfrich","year":"2018","journal-title":"J Eval Clin Pract"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13012-022-01186-8","article-title":"Promoting de-implementation of inappropriate antimicrobial use in cardiac device procedures by expanding audit and feedback: protocol for hybrid III type effectiveness\/implementation quasi-experimental study","volume":"17","author":"Branch-Elliman","year":"2022","journal-title":"Implement Sci"},{"key":"ref21","year":"2023"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-publhealth-031816-044215","article-title":"An overview of research and evaluation designs for dissemination and implementation","volume":"38","author":"Brown","year":"2017","journal-title":"Annu Rev Public Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13012-016-0398-2","article-title":"PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice","volume":"11","author":"Harvey","year":"2016","journal-title":"Implement Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the expert recommendations for implementing change (ERIC) project","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"key":"ref26","year":"2018"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1017\/ash.2023.420","article-title":"Engaging patients in antimicrobial stewardship: co-designed educational tool to improve periprocedural care through de-implementation of guideline-discordant antimicrobial use","volume":"3","author":"Al Lawati","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e2514079","DOI":"10.1001\/jamanetworkopen.2025.14079","article-title":"Cardiac implantable device infection surveillance algorithm","volume":"8","author":"Mull","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12911-020-1031-5","article-title":"Novel methodology to measure pre-procedure antimicrobial prophylaxis: integrating text searches with structured data from the veterans health administration's electronic medical record","volume":"20","author":"Mull","year":"2020","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e2012264","DOI":"10.1001\/jamanetworkopen.2020.12264","article-title":"Novel method to flag cardiac implantable device infections by integrating text mining with structured data in the veterans health administration's electronic medical record","volume":"3","author":"Mull","year":"2020","journal-title":"JAMA Netw Open"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e2313964","DOI":"10.1001\/jamanetworkopen.2023.13964","article-title":"A novel informatics tool to detect Periprocedural antibiotic allergy adverse events for near real-time surveillance to support audit and feedback","volume":"6","author":"Reyes Dassum","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref32","year":"2025"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","article-title":"Design and analysis of stepped wedge cluster randomized trials","volume":"28","author":"Hussey","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"112516","DOI":"10.1016\/j.psychres.2019.112516","article-title":"Qualitative methods in implementation research: an introduction","volume":"280","author":"Hamilton","year":"2019","journal-title":"Psychiatry Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Admin Pol Ment Health"},{"key":"ref37","volume-title":"Qualitative Methods in rapid turn-around Health Services Research. Health Services Research & Development Cyberseminar","author":"Hamilton","year":"2013"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s43058-022-00344-9","article-title":"Development of a qualitative data analysis codebook informed by the i-PARIHS framework","volume":"3","author":"Ritchie","year":"2022","journal-title":"Implementation Sci Commun"},{"key":"ref40","volume-title":"Qualitative data Analysis: A Methods Sourcebook","author":"Huberman","year":"2014"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1893058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:20:37Z","timestamp":1790144437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1893058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":40,"alternative-id":["10.3389\/fpubh.2026.1893058"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1893058","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1893058"}}